Universitätsklinikum Augsburg

Hospital


Location: Augsburg, Germany (DE) DE

ISNI: 0000000093120220

ROR: https://ror.org/03b0k9c14

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study (2019) Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, et al. Journal article Association of Intrathecal Immunoglobulin G Synthesis with Disability Worsening in Multiple Sclerosis (2019) Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker R, et al. Journal article Next-generation reference intervals for pediatric hematology (2019) Zierk J, Hirschmann J, Toddenroth D, Arzideh F, Haeckel R, Bertram A, Cario H, et al. Journal article Quality of life of short-statured children born small for gestational age or idiopathic growth hormone deficiency within one year of growth hormone treatment (2019) Quitmann J, Bloemeke J, Silva N, Bullinger M, Witt S, Akkurt I, Dunstheimer D, et al. Journal article Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation (2019) Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, et al. Journal article Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) Von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, et al. Journal article Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) Ambrosius B, Hessler N, Antony G, Konig IR, Hoshi MM, Aly L, Luessi F, et al. Conference contribution DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study (2018) Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, et al. Journal article The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis (2018) Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, et al. Journal article